Organigram (OGI) Expected to Announce Quarterly Earnings on Tuesday

Organigram (NASDAQ:OGI) is expected to announce its earnings results before the market opens on Tuesday, February 11th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $48.94 million for the quarter.

Organigram (NASDAQ:OGI) last posted its quarterly earnings data on Wednesday, December 18th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Organigram had a negative net margin of 28.58% and a negative return on equity of 11.68%. On average, analysts expect Organigram to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Organigram Stock Down 3.3 %

Shares of OGI opened at $1.45 on Tuesday. Organigram has a fifty-two week low of $1.31 and a fifty-two week high of $2.91. The company has a market cap of $182.93 million, a P/E ratio of -3.82 and a beta of 1.00. The firm’s 50 day moving average price is $1.55 and its 200 day moving average price is $1.67.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.